Alkem Laboratories Ltd.NSE: ALKEM

Press Release Sep 22 2025

· Issued by Alkem Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-22-2025-7

Alkem Laboratories Limited has informed the Exchange regarding a press release dated September 22, 2025, titled "Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer.".

View Attachment

6ix hasn’t read this filing yet.

Alkem Laboratories Ltd. on 6ix

Earlier from Alkem Laboratories

Later from Alkem Laboratories

All Alkem Laboratories news releases